2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf6
|
ENSMUSG00000000078.6 | Kruppel-like factor 6 |
Patz1
|
ENSMUSG00000020453.11 | POZ (BTB) and AT hook containing zinc finger 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Klf6 | mm10_v2_chr13_+_5861489_5861501 | -0.70 | 1.1e-02 | Click! |
Patz1 | mm10_v2_chr11_+_3289880_3289993 | -0.69 | 1.2e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_-_102296618 | 6.63 |
ENSMUST00000107132.2
ENSMUST00000073234.2 |
Atxn7l3
|
ataxin 7-like 3 |
chr9_+_59578192 | 3.81 |
ENSMUST00000118549.1
ENSMUST00000034840.3 |
Celf6
|
CUGBP, Elav-like family member 6 |
chr7_-_128237984 | 3.37 |
ENSMUST00000078816.3
|
9130023H24Rik
|
RIKEN cDNA 9130023H24 gene |
chr13_-_71963713 | 3.29 |
ENSMUST00000077337.8
|
Irx1
|
Iroquois related homeobox 1 (Drosophila) |
chr15_-_32244632 | 3.11 |
ENSMUST00000181536.1
|
0610007N19Rik
|
RIKEN cDNA 0610007N19 |
chr15_-_76521902 | 3.02 |
ENSMUST00000164703.1
ENSMUST00000096365.3 |
Scrt1
|
scratch homolog 1, zinc finger protein (Drosophila) |
chr4_-_43046196 | 2.97 |
ENSMUST00000036462.5
|
Fam214b
|
family with sequence similarity 214, member B |
chr17_+_72836678 | 2.91 |
ENSMUST00000045174.5
|
Ypel5
|
yippee-like 5 (Drosophila) |
chr4_+_120854786 | 2.73 |
ENSMUST00000071093.2
|
Rims3
|
regulating synaptic membrane exocytosis 3 |
chr11_-_69122589 | 2.49 |
ENSMUST00000180487.1
|
9130213A22Rik
|
RIKEN cDNA 9130213A22 gene |
chr4_-_43045686 | 2.44 |
ENSMUST00000107956.1
ENSMUST00000107957.1 |
Fam214b
|
family with sequence similarity 214, member B |
chr12_+_24651346 | 2.42 |
ENSMUST00000020982.5
|
Klf11
|
Kruppel-like factor 11 |
chr17_+_26933070 | 2.35 |
ENSMUST00000073724.5
|
Phf1
|
PHD finger protein 1 |
chr16_-_22439570 | 2.32 |
ENSMUST00000170393.1
|
Etv5
|
ets variant gene 5 |
chr3_-_8667033 | 2.29 |
ENSMUST00000042412.3
|
Hey1
|
hairy/enhancer-of-split related with YRPW motif 1 |
chr7_+_141079759 | 2.28 |
ENSMUST00000066873.4
ENSMUST00000163041.1 |
Pkp3
|
plakophilin 3 |
chr13_+_12565868 | 2.22 |
ENSMUST00000071973.6
|
Ero1lb
|
ERO1-like beta (S. cerevisiae) |
chr8_+_47675362 | 2.20 |
ENSMUST00000098781.2
|
AA386476
|
expressed sequence AA386476 |
chr12_-_84698769 | 2.20 |
ENSMUST00000095550.2
|
Syndig1l
|
synapse differentiation inducing 1 like |
chr11_+_97799772 | 2.19 |
ENSMUST00000129558.1
|
Lasp1
|
LIM and SH3 protein 1 |
chr17_+_24752980 | 2.14 |
ENSMUST00000044922.6
|
Hs3st6
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 6 |
chr19_-_10457447 | 2.13 |
ENSMUST00000171400.2
|
Lrrc10b
|
leucine rich repeat containing 10B |
chr10_+_80167778 | 2.12 |
ENSMUST00000105365.2
ENSMUST00000054666.6 |
Cirbp
|
cold inducible RNA binding protein |
chr4_-_114908892 | 2.10 |
ENSMUST00000068654.3
|
Foxd2
|
forkhead box D2 |
chr8_-_90908415 | 1.95 |
ENSMUST00000098517.1
|
Gm6658
|
predicted gene 6658 |
chr18_-_24709348 | 1.92 |
ENSMUST00000067987.1
|
Gm9955
|
predicted gene 9955 |
chr4_+_138454305 | 1.84 |
ENSMUST00000050918.3
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr9_-_57836706 | 1.84 |
ENSMUST00000164010.1
ENSMUST00000171444.1 ENSMUST00000098686.3 |
Arid3b
|
AT rich interactive domain 3B (BRIGHT-like) |
chr5_-_138996087 | 1.83 |
ENSMUST00000110897.1
|
Pdgfa
|
platelet derived growth factor, alpha |
chr17_-_25256274 | 1.81 |
ENSMUST00000182435.1
ENSMUST00000169109.2 ENSMUST00000182056.1 |
Baiap3
|
BAI1-associated protein 3 |
chr5_+_108694222 | 1.81 |
ENSMUST00000013633.8
ENSMUST00000112560.3 |
Fgfrl1
|
fibroblast growth factor receptor-like 1 |
chr5_+_137288273 | 1.79 |
ENSMUST00000024099.4
ENSMUST00000085934.3 |
Ache
|
acetylcholinesterase |
chr12_-_4841583 | 1.79 |
ENSMUST00000020964.5
|
Fkbp1b
|
FK506 binding protein 1b |
chr15_+_87625214 | 1.78 |
ENSMUST00000068088.6
|
Fam19a5
|
family with sequence similarity 19, member A5 |
chr16_+_20733104 | 1.74 |
ENSMUST00000115423.1
ENSMUST00000007171.6 |
Chrd
|
chordin |
chr7_+_25268387 | 1.73 |
ENSMUST00000169392.1
|
Cic
|
capicua homolog (Drosophila) |
chr15_-_100599983 | 1.72 |
ENSMUST00000073837.6
|
Pou6f1
|
POU domain, class 6, transcription factor 1 |
chr4_-_129239165 | 1.71 |
ENSMUST00000097873.3
|
C77080
|
expressed sequence C77080 |
chr19_+_55741810 | 1.70 |
ENSMUST00000111657.3
ENSMUST00000061496.9 ENSMUST00000041717.7 ENSMUST00000111662.4 |
Tcf7l2
|
transcription factor 7 like 2, T cell specific, HMG box |
chr7_+_44310213 | 1.69 |
ENSMUST00000107938.1
|
Shank1
|
SH3/ankyrin domain gene 1 |
chr11_+_114765363 | 1.68 |
ENSMUST00000138804.1
ENSMUST00000084368.5 |
Kif19a
|
kinesin family member 19A |
chr11_+_69991633 | 1.68 |
ENSMUST00000108592.1
|
Gabarap
|
gamma-aminobutyric acid receptor associated protein |
chr1_-_74885322 | 1.67 |
ENSMUST00000159232.1
ENSMUST00000068631.3 |
Fev
|
FEV (ETS oncogene family) |
chr7_-_143460989 | 1.66 |
ENSMUST00000167912.1
ENSMUST00000037287.6 |
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C (P57) |
chr4_+_141242850 | 1.65 |
ENSMUST00000138096.1
ENSMUST00000006618.2 ENSMUST00000125392.1 |
Arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
chr2_+_174760619 | 1.63 |
ENSMUST00000029030.2
|
Edn3
|
endothelin 3 |
chr1_-_184033998 | 1.63 |
ENSMUST00000050306.5
|
1700056E22Rik
|
RIKEN cDNA 1700056E22 gene |
chr8_-_84067283 | 1.60 |
ENSMUST00000071067.3
|
C330011M18Rik
|
RIKEN cDNA C330011M18 gene |
chr11_-_95514570 | 1.60 |
ENSMUST00000058866.7
|
Nxph3
|
neurexophilin 3 |
chr16_-_18586959 | 1.59 |
ENSMUST00000009241.5
|
Tbx1
|
T-box 1 |
chr4_+_136247932 | 1.59 |
ENSMUST00000102533.4
ENSMUST00000143942.1 |
Tcea3
|
transcription elongation factor A (SII), 3 |
chr17_+_24488773 | 1.59 |
ENSMUST00000024958.7
|
Caskin1
|
CASK interacting protein 1 |
chr9_-_121759788 | 1.58 |
ENSMUST00000181325.1
|
E530011L22Rik
|
RIKEN cDNA E530011L22 gene |
chr3_+_96697100 | 1.57 |
ENSMUST00000107077.3
|
Pias3
|
protein inhibitor of activated STAT 3 |
chr1_-_172206684 | 1.57 |
ENSMUST00000155109.1
|
Pea15a
|
phosphoprotein enriched in astrocytes 15A |
chr15_-_75566811 | 1.57 |
ENSMUST00000065417.8
|
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr7_+_49975228 | 1.55 |
ENSMUST00000107603.1
|
Nell1
|
NEL-like 1 |
chr15_-_75566608 | 1.54 |
ENSMUST00000163116.1
ENSMUST00000023241.5 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr9_+_114978507 | 1.54 |
ENSMUST00000183104.1
|
Osbpl10
|
oxysterol binding protein-like 10 |
chr17_-_24533709 | 1.54 |
ENSMUST00000061764.7
|
Rab26
|
RAB26, member RAS oncogene family |
chr18_-_3337467 | 1.51 |
ENSMUST00000154135.1
|
Crem
|
cAMP responsive element modulator |
chr5_+_73491026 | 1.50 |
ENSMUST00000063882.5
ENSMUST00000113558.1 |
Dcun1d4
|
DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae) |
chr7_+_49974864 | 1.50 |
ENSMUST00000081872.5
ENSMUST00000151721.1 |
Nell1
|
NEL-like 1 |
chr17_+_35823509 | 1.50 |
ENSMUST00000173493.1
ENSMUST00000173147.1 ENSMUST00000172846.1 |
Flot1
|
flotillin 1 |
chr3_+_28263205 | 1.49 |
ENSMUST00000159236.2
|
Tnik
|
TRAF2 and NCK interacting kinase |
chr7_-_19629355 | 1.46 |
ENSMUST00000049912.8
ENSMUST00000094762.3 ENSMUST00000098754.4 |
Relb
|
avian reticuloendotheliosis viral (v-rel) oncogene related B |
chr15_-_75747922 | 1.46 |
ENSMUST00000062002.4
|
Mafa
|
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (avian) |
chr1_-_134235420 | 1.44 |
ENSMUST00000038191.6
ENSMUST00000086465.4 |
Adora1
|
adenosine A1 receptor |
chr7_-_27396542 | 1.42 |
ENSMUST00000108363.1
|
Sptbn4
|
spectrin beta, non-erythrocytic 4 |
chr7_-_29168647 | 1.42 |
ENSMUST00000048923.6
|
Spred3
|
sprouty-related, EVH1 domain containing 3 |
chr11_+_69964758 | 1.42 |
ENSMUST00000108597.1
ENSMUST00000060651.5 ENSMUST00000108596.1 |
Cldn7
|
claudin 7 |
chr16_-_22439719 | 1.41 |
ENSMUST00000079601.6
|
Etv5
|
ets variant gene 5 |
chr2_+_19445632 | 1.40 |
ENSMUST00000028068.2
|
Ptf1a
|
pancreas specific transcription factor, 1a |
chr1_-_172206775 | 1.39 |
ENSMUST00000013842.5
ENSMUST00000111247.1 |
Pea15a
|
phosphoprotein enriched in astrocytes 15A |
chr4_+_43046014 | 1.39 |
ENSMUST00000180426.1
|
Gm26881
|
predicted gene, 26881 |
chr1_-_84696182 | 1.38 |
ENSMUST00000049126.6
|
Dner
|
delta/notch-like EGF-related receptor |
chr3_-_89387132 | 1.38 |
ENSMUST00000107433.1
|
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr4_-_117872520 | 1.38 |
ENSMUST00000171052.1
ENSMUST00000166325.1 ENSMUST00000106422.2 |
Ccdc24
|
coiled-coil domain containing 24 |
chr1_-_9967932 | 1.37 |
ENSMUST00000185184.1
|
Tcf24
|
transcription factor 24 |
chr7_-_68749170 | 1.37 |
ENSMUST00000118110.1
ENSMUST00000048068.7 |
Arrdc4
|
arrestin domain containing 4 |
chr4_+_101647763 | 1.35 |
ENSMUST00000106927.1
|
Leprot
|
leptin receptor overlapping transcript |
chr5_-_24351604 | 1.33 |
ENSMUST00000036092.7
|
Kcnh2
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
chr8_+_105413614 | 1.33 |
ENSMUST00000109355.2
|
Lrrc36
|
leucine rich repeat containing 36 |
chr2_-_29253001 | 1.33 |
ENSMUST00000071201.4
|
Ntng2
|
netrin G2 |
chr4_+_139380658 | 1.33 |
ENSMUST00000165860.1
ENSMUST00000097822.3 |
Ubr4
|
ubiquitin protein ligase E3 component n-recognin 4 |
chr8_+_105305572 | 1.32 |
ENSMUST00000109375.2
|
Elmo3
|
engulfment and cell motility 3 |
chr5_+_113735782 | 1.32 |
ENSMUST00000065698.5
|
Ficd
|
FIC domain containing |
chr7_-_100658394 | 1.31 |
ENSMUST00000138830.1
ENSMUST00000107044.3 ENSMUST00000116287.2 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr19_+_5298302 | 1.30 |
ENSMUST00000061169.6
|
Gal3st3
|
galactose-3-O-sulfotransferase 3 |
chr1_+_191906743 | 1.30 |
ENSMUST00000044954.6
|
Slc30a1
|
solute carrier family 30 (zinc transporter), member 1 |
chr2_-_59160644 | 1.29 |
ENSMUST00000077687.5
|
Ccdc148
|
coiled-coil domain containing 148 |
chr17_+_29490812 | 1.28 |
ENSMUST00000024811.6
|
Pim1
|
proviral integration site 1 |
chr14_+_30715599 | 1.28 |
ENSMUST00000054230.4
|
Sfmbt1
|
Scm-like with four mbt domains 1 |
chr9_+_50752758 | 1.28 |
ENSMUST00000034562.7
|
Cryab
|
crystallin, alpha B |
chr17_+_46681038 | 1.27 |
ENSMUST00000002845.6
|
Mea1
|
male enhanced antigen 1 |
chr4_-_151996113 | 1.27 |
ENSMUST00000055688.9
|
Phf13
|
PHD finger protein 13 |
chr4_+_45012830 | 1.27 |
ENSMUST00000095105.1
|
1700055D18Rik
|
RIKEN cDNA 1700055D18 gene |
chr19_+_4510472 | 1.26 |
ENSMUST00000068004.6
|
Pcx
|
pyruvate carboxylase |
chr11_+_69765970 | 1.26 |
ENSMUST00000108642.1
ENSMUST00000156932.1 |
Zbtb4
|
zinc finger and BTB domain containing 4 |
chr1_+_120340569 | 1.26 |
ENSMUST00000037286.8
|
C1ql2
|
complement component 1, q subcomponent-like 2 |
chrX_-_47892502 | 1.25 |
ENSMUST00000077569.4
ENSMUST00000101616.2 ENSMUST00000088973.4 |
Smarca1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
chr6_-_124768330 | 1.24 |
ENSMUST00000135626.1
|
Eno2
|
enolase 2, gamma neuronal |
chr9_-_53706211 | 1.24 |
ENSMUST00000068449.3
|
Rab39
|
RAB39, member RAS oncogene family |
chr7_-_79842287 | 1.24 |
ENSMUST00000049004.6
|
Anpep
|
alanyl (membrane) aminopeptidase |
chr14_-_52279238 | 1.24 |
ENSMUST00000167116.1
ENSMUST00000100631.4 |
Rab2b
|
RAB2B, member RAS oncogene family |
chr12_-_86884808 | 1.23 |
ENSMUST00000038422.6
|
Irf2bpl
|
interferon regulatory factor 2 binding protein-like |
chr16_-_20621255 | 1.23 |
ENSMUST00000052939.2
|
Camk2n2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
chr11_+_69088490 | 1.23 |
ENSMUST00000021273.6
ENSMUST00000117780.1 |
Vamp2
|
vesicle-associated membrane protein 2 |
chr7_-_100658364 | 1.22 |
ENSMUST00000107043.1
|
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr17_-_46629420 | 1.22 |
ENSMUST00000044442.8
|
Ptk7
|
PTK7 protein tyrosine kinase 7 |
chr7_+_29170204 | 1.22 |
ENSMUST00000098609.2
|
Ggn
|
gametogenetin |
chr11_-_106160101 | 1.22 |
ENSMUST00000045923.3
|
Limd2
|
LIM domain containing 2 |
chr5_+_104459450 | 1.22 |
ENSMUST00000086831.3
|
Pkd2
|
polycystic kidney disease 2 |
chr7_+_29170345 | 1.21 |
ENSMUST00000033886.7
|
Ggn
|
gametogenetin |
chr11_+_97799565 | 1.20 |
ENSMUST00000043843.5
|
Lasp1
|
LIM and SH3 protein 1 |
chr4_-_154025657 | 1.20 |
ENSMUST00000146426.1
|
Smim1
|
small integral membrane protein 1 |
chr6_+_119848193 | 1.20 |
ENSMUST00000062454.1
|
3110021A11Rik
|
RIKEN cDNA 3110021A11 gene |
chr2_+_91457501 | 1.19 |
ENSMUST00000028689.3
|
Lrp4
|
low density lipoprotein receptor-related protein 4 |
chr7_+_121865070 | 1.19 |
ENSMUST00000033161.5
|
Scnn1b
|
sodium channel, nonvoltage-gated 1 beta |
chrX_-_135009185 | 1.19 |
ENSMUST00000113185.2
ENSMUST00000064659.5 |
Zmat1
|
zinc finger, matrin type 1 |
chr3_-_89093358 | 1.19 |
ENSMUST00000090929.5
ENSMUST00000052539.6 |
Rusc1
|
RUN and SH3 domain containing 1 |
chr4_+_136310936 | 1.18 |
ENSMUST00000131671.1
|
Hnrnpr
|
heterogeneous nuclear ribonucleoprotein R |
chrX_-_59134421 | 1.17 |
ENSMUST00000033473.5
|
Fgf13
|
fibroblast growth factor 13 |
chr17_-_33760306 | 1.16 |
ENSMUST00000173860.1
|
Rab11b
|
RAB11B, member RAS oncogene family |
chr2_-_24048857 | 1.16 |
ENSMUST00000114497.1
|
Hnmt
|
histamine N-methyltransferase |
chr4_+_152338887 | 1.16 |
ENSMUST00000005175.4
|
Chd5
|
chromodomain helicase DNA binding protein 5 |
chr10_+_127290774 | 1.15 |
ENSMUST00000026475.8
ENSMUST00000139091.1 |
Ddit3
|
DNA-damage inducible transcript 3 |
chr4_+_43669266 | 1.15 |
ENSMUST00000107864.1
|
Tmem8b
|
transmembrane protein 8B |
chr2_-_153529941 | 1.15 |
ENSMUST00000035346.7
|
8430427H17Rik
|
RIKEN cDNA 8430427H17 gene |
chr10_-_80139347 | 1.14 |
ENSMUST00000105369.1
|
Dos
|
downstream of Stk11 |
chr19_+_8920358 | 1.13 |
ENSMUST00000096243.5
|
B3gat3
|
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
chr17_-_24209377 | 1.13 |
ENSMUST00000024931.4
|
Ntn3
|
netrin 3 |
chr4_+_101647712 | 1.13 |
ENSMUST00000030254.8
|
Leprot
|
leptin receptor overlapping transcript |
chr8_-_90348126 | 1.12 |
ENSMUST00000176034.1
ENSMUST00000176616.1 |
Tox3
|
TOX high mobility group box family member 3 |
chr7_-_19166119 | 1.12 |
ENSMUST00000094790.3
|
Gipr
|
gastric inhibitory polypeptide receptor |
chr19_+_55741884 | 1.12 |
ENSMUST00000111658.3
ENSMUST00000111654.1 |
Tcf7l2
|
transcription factor 7 like 2, T cell specific, HMG box |
chr4_-_43669141 | 1.12 |
ENSMUST00000056474.6
|
Fam221b
|
family with sequence similarity 221, member B |
chr19_-_42752710 | 1.12 |
ENSMUST00000076505.3
|
Pyroxd2
|
pyridine nucleotide-disulphide oxidoreductase domain 2 |
chr12_-_79007276 | 1.11 |
ENSMUST00000056660.6
ENSMUST00000174721.1 |
Tmem229b
|
transmembrane protein 229B |
chr17_+_24696234 | 1.11 |
ENSMUST00000019464.7
|
Noxo1
|
NADPH oxidase organizer 1 |
chr17_+_35866056 | 1.11 |
ENSMUST00000122899.1
|
Ppp1r18
|
protein phosphatase 1, regulatory subunit 18 |
chr5_-_93045022 | 1.11 |
ENSMUST00000061328.5
|
Sowahb
|
sosondowah ankyrin repeat domain family member B |
chr19_+_55742242 | 1.11 |
ENSMUST00000111652.1
ENSMUST00000111649.1 ENSMUST00000111651.1 ENSMUST00000111653.1 ENSMUST00000111656.1 ENSMUST00000127233.1 ENSMUST00000153888.1 |
Tcf7l2
|
transcription factor 7 like 2, T cell specific, HMG box |
chr6_-_86669136 | 1.11 |
ENSMUST00000001184.7
|
Mxd1
|
MAX dimerization protein 1 |
chr2_-_38287347 | 1.11 |
ENSMUST00000102787.3
|
Dennd1a
|
DENN/MADD domain containing 1A |
chr4_+_43669610 | 1.10 |
ENSMUST00000107866.1
|
Tmem8b
|
transmembrane protein 8B |
chrX_+_159627265 | 1.10 |
ENSMUST00000112456.2
|
Sh3kbp1
|
SH3-domain kinase binding protein 1 |
chr11_+_102604370 | 1.10 |
ENSMUST00000057893.5
|
Fzd2
|
frizzled homolog 2 (Drosophila) |
chr11_+_69965396 | 1.09 |
ENSMUST00000018713.6
|
Cldn7
|
claudin 7 |
chr16_+_44173271 | 1.09 |
ENSMUST00000088356.4
ENSMUST00000169582.1 |
Gm608
|
predicted gene 608 |
chr19_+_6341121 | 1.09 |
ENSMUST00000025897.6
ENSMUST00000130382.1 |
Map4k2
|
mitogen-activated protein kinase kinase kinase kinase 2 |
chr18_+_74442500 | 1.09 |
ENSMUST00000074157.6
|
Myo5b
|
myosin VB |
chr5_+_30588078 | 1.09 |
ENSMUST00000066295.2
|
Kcnk3
|
potassium channel, subfamily K, member 3 |
chr6_-_83033422 | 1.09 |
ENSMUST00000089651.5
|
Dok1
|
docking protein 1 |
chr1_+_125561010 | 1.08 |
ENSMUST00000027580.4
|
Slc35f5
|
solute carrier family 35, member F5 |
chr11_-_100414829 | 1.08 |
ENSMUST00000066489.6
|
Leprel4
|
leprecan-like 4 |
chr8_-_89044162 | 1.07 |
ENSMUST00000034090.6
|
Sall1
|
sal-like 1 (Drosophila) |
chr11_-_119086221 | 1.07 |
ENSMUST00000026665.7
|
Cbx4
|
chromobox 4 |
chr19_+_6399857 | 1.06 |
ENSMUST00000146601.1
ENSMUST00000150713.1 |
Rasgrp2
|
RAS, guanyl releasing protein 2 |
chr19_-_8929323 | 1.06 |
ENSMUST00000096242.3
|
Rom1
|
rod outer segment membrane protein 1 |
chr11_-_106159902 | 1.06 |
ENSMUST00000064545.4
|
Limd2
|
LIM domain containing 2 |
chr15_+_76671615 | 1.05 |
ENSMUST00000037551.8
|
Ppp1r16a
|
protein phosphatase 1, regulatory (inhibitor) subunit 16A |
chr7_+_44384604 | 1.05 |
ENSMUST00000130707.1
ENSMUST00000130844.1 |
Syt3
|
synaptotagmin III |
chr6_+_86526271 | 1.05 |
ENSMUST00000180896.1
|
1600020E01Rik
|
RIKEN cDNA 1600020E01 gene |
chr4_-_45012287 | 1.04 |
ENSMUST00000055028.8
ENSMUST00000180217.1 ENSMUST00000107817.2 |
Zbtb5
|
zinc finger and BTB domain containing 5 |
chr7_-_44816586 | 1.04 |
ENSMUST00000047356.8
|
Atf5
|
activating transcription factor 5 |
chr7_+_3645267 | 1.04 |
ENSMUST00000038913.9
|
Cnot3
|
CCR4-NOT transcription complex, subunit 3 |
chr5_-_52471534 | 1.04 |
ENSMUST00000059428.5
|
Ccdc149
|
coiled-coil domain containing 149 |
chr4_-_134704235 | 1.04 |
ENSMUST00000054096.6
ENSMUST00000038628.3 |
Man1c1
|
mannosidase, alpha, class 1C, member 1 |
chr1_-_124045247 | 1.04 |
ENSMUST00000112603.2
|
Dpp10
|
dipeptidylpeptidase 10 |
chr5_+_24428208 | 1.04 |
ENSMUST00000115049.2
|
Slc4a2
|
solute carrier family 4 (anion exchanger), member 2 |
chr17_-_46680870 | 1.03 |
ENSMUST00000165007.1
ENSMUST00000071841.5 |
Klhdc3
|
kelch domain containing 3 |
chr18_-_3337539 | 1.03 |
ENSMUST00000142690.1
ENSMUST00000025069.4 ENSMUST00000082141.5 ENSMUST00000165086.1 ENSMUST00000149803.1 |
Crem
|
cAMP responsive element modulator |
chr19_-_58454580 | 1.02 |
ENSMUST00000129100.1
ENSMUST00000123957.1 |
Gfra1
|
glial cell line derived neurotrophic factor family receptor alpha 1 |
chr1_+_184034381 | 1.02 |
ENSMUST00000048655.7
|
Dusp10
|
dual specificity phosphatase 10 |
chr5_+_115631902 | 1.02 |
ENSMUST00000031492.8
|
Rab35
|
RAB35, member RAS oncogene family |
chr15_-_97831460 | 1.01 |
ENSMUST00000079838.7
ENSMUST00000118294.1 |
Hdac7
|
histone deacetylase 7 |
chr4_+_110397661 | 1.01 |
ENSMUST00000106589.2
ENSMUST00000106587.2 ENSMUST00000106591.1 ENSMUST00000106592.1 |
Agbl4
|
ATP/GTP binding protein-like 4 |
chr12_+_112620030 | 1.00 |
ENSMUST00000180015.1
ENSMUST00000021726.6 |
Adssl1
|
adenylosuccinate synthetase like 1 |
chr4_+_43875524 | 1.00 |
ENSMUST00000030198.6
|
Reck
|
reversion-inducing-cysteine-rich protein with kazal motifs |
chr6_+_115774538 | 0.99 |
ENSMUST00000075995.5
|
Cand2
|
cullin-associated and neddylation-dissociated 2 (putative) |
chr4_+_110397764 | 0.99 |
ENSMUST00000097920.2
ENSMUST00000080744.6 |
Agbl4
|
ATP/GTP binding protein-like 4 |
chr5_-_138279960 | 0.99 |
ENSMUST00000014089.7
ENSMUST00000161827.1 |
Gpc2
|
glypican 2 (cerebroglycan) |
chr2_+_84734050 | 0.99 |
ENSMUST00000090729.2
|
Ypel4
|
yippee-like 4 (Drosophila) |
chr11_-_97699634 | 0.98 |
ENSMUST00000103148.1
ENSMUST00000169807.1 |
Pcgf2
|
polycomb group ring finger 2 |
chr7_+_19094594 | 0.98 |
ENSMUST00000049454.5
|
Six5
|
sine oculis-related homeobox 5 |
chr17_+_35823230 | 0.98 |
ENSMUST00000001569.8
ENSMUST00000174080.1 |
Flot1
|
flotillin 1 |
chr16_+_44173239 | 0.98 |
ENSMUST00000119746.1
|
Gm608
|
predicted gene 608 |
chr11_+_85832551 | 0.98 |
ENSMUST00000000095.6
|
Tbx2
|
T-box 2 |
chr14_-_20794009 | 0.97 |
ENSMUST00000100837.3
ENSMUST00000080440.6 ENSMUST00000071816.6 |
Camk2g
|
calcium/calmodulin-dependent protein kinase II gamma |
chr9_-_121792478 | 0.97 |
ENSMUST00000035110.4
|
Hhatl
|
hedgehog acyltransferase-like |
chr11_-_69695802 | 0.97 |
ENSMUST00000108649.1
ENSMUST00000174159.1 ENSMUST00000181810.1 |
BC096441
Tnfsf12
|
cDNA sequence BC096441 tumor necrosis factor (ligand) superfamily, member 12 |
chr15_+_81811414 | 0.96 |
ENSMUST00000023024.7
|
Tef
|
thyrotroph embryonic factor |
chr11_-_69695521 | 0.96 |
ENSMUST00000181261.1
|
Tnfsf12
|
tumor necrosis factor (ligand) superfamily, member 12 |
chr10_-_30842765 | 0.96 |
ENSMUST00000019924.8
|
Hey2
|
hairy/enhancer-of-split related with YRPW motif 2 |
chr10_-_93310963 | 0.96 |
ENSMUST00000151153.1
|
Elk3
|
ELK3, member of ETS oncogene family |
chr5_+_8422831 | 0.96 |
ENSMUST00000066921.3
|
Slc25a40
|
solute carrier family 25, member 40 |
chr15_-_100599864 | 0.95 |
ENSMUST00000177247.2
ENSMUST00000177505.2 |
Pou6f1
|
POU domain, class 6, transcription factor 1 |
chr5_+_90786100 | 0.95 |
ENSMUST00000031326.8
|
Cxcl3
|
chemokine (C-X-C motif) ligand 3 |
chr19_+_6418731 | 0.95 |
ENSMUST00000113462.1
ENSMUST00000077182.6 ENSMUST00000113461.1 |
Nrxn2
|
neurexin II |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 4.3 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.9 | 3.6 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.9 | 5.3 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.8 | 2.4 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.6 | 1.9 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.6 | 2.3 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.6 | 2.2 | GO:0030070 | insulin processing(GO:0030070) |
0.6 | 5.0 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.5 | 2.2 | GO:0034031 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
0.5 | 2.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.5 | 2.1 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.5 | 1.6 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.5 | 3.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.5 | 2.4 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.5 | 1.5 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.5 | 2.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.5 | 2.4 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.5 | 1.4 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.5 | 1.8 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.4 | 1.3 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.4 | 1.3 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.4 | 1.7 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.4 | 1.3 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.4 | 2.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.4 | 1.2 | GO:0009726 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
0.4 | 2.4 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.4 | 2.4 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.4 | 1.2 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.4 | 0.4 | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.4 | 2.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.4 | 0.8 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.4 | 1.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 2.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 1.7 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 2.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 1.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.3 | 0.3 | GO:0019049 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.3 | 1.0 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.3 | 2.3 | GO:0051775 | response to redox state(GO:0051775) |
0.3 | 1.0 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 1.0 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.3 | 2.3 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.3 | 1.3 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.3 | 2.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.3 | 1.9 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.3 | 1.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 0.6 | GO:2000850 | negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.3 | 1.9 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 3.6 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.3 | 1.5 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.3 | 2.1 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.3 | 1.8 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 1.2 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.3 | 0.9 | GO:0035627 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
0.3 | 1.2 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.3 | 0.9 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.3 | 2.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.3 | 0.9 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.3 | 1.7 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 1.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.3 | 2.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 1.4 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.3 | 0.8 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.3 | 0.3 | GO:0036482 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
0.3 | 0.3 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.3 | 1.1 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.3 | 0.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 0.3 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.3 | 0.8 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
0.3 | 0.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.7 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.2 | 0.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.2 | 1.0 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 1.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.2 | 0.7 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.2 | 1.2 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.2 | 2.1 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.2 | 0.7 | GO:0046449 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) |
0.2 | 0.7 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.2 | 0.7 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.2 | 0.7 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.2 | 1.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.2 | 0.7 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 1.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.7 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 2.2 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.2 | 0.7 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 2.2 | GO:0046959 | habituation(GO:0046959) |
0.2 | 0.9 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.2 | 0.7 | GO:0015866 | ADP transport(GO:0015866) |
0.2 | 0.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 0.7 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.2 | 0.7 | GO:1903465 | motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) positive regulation of mitotic cell cycle DNA replication(GO:1903465) |
0.2 | 0.9 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.2 | 0.7 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 1.7 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 0.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 1.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.8 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.4 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
0.2 | 1.9 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.2 | 0.8 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.2 | 0.2 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.2 | 1.2 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.2 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.2 | 1.8 | GO:0051611 | regulation of serotonin uptake(GO:0051611) |
0.2 | 0.8 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.2 | 1.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 1.4 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 1.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 0.4 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 1.6 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 1.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.2 | 1.6 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.2 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 1.2 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.2 | 1.0 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 2.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.2 | 3.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.4 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
0.2 | 2.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 0.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 0.5 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.2 | 0.9 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.2 | 0.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.2 | 0.7 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.2 | 0.7 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) fatty-acyl-CoA catabolic process(GO:0036115) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.2 | 2.5 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.2 | 0.2 | GO:1903179 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.2 | 0.5 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.2 | 0.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 0.5 | GO:1904978 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.2 | 0.3 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.2 | 1.2 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.2 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.5 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
0.2 | 0.7 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 0.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 0.5 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.5 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.2 | 0.8 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 0.3 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
0.2 | 1.2 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.2 | 0.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.2 | 0.5 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.2 | 0.2 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 0.5 | GO:0046710 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
0.2 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.2 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.2 | 0.5 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.5 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.2 | 0.5 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
0.2 | 0.6 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.2 | 0.8 | GO:0042117 | monocyte activation(GO:0042117) |
0.2 | 1.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.2 | 0.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 2.5 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 0.2 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
0.2 | 0.9 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.3 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) negative regulation of mast cell apoptotic process(GO:0033026) |
0.2 | 1.1 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.2 | 0.8 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 1.6 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.4 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
0.1 | 1.0 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.4 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.4 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.3 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.1 | 0.8 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 0.4 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.1 | 0.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.4 | GO:0060466 | activation of meiosis involved in egg activation(GO:0060466) |
0.1 | 0.4 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 0.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.6 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 0.7 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.1 | 0.3 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.1 | 0.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 1.0 | GO:0015675 | nickel cation transport(GO:0015675) |
0.1 | 0.3 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.1 | 0.3 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.1 | 2.6 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.1 | GO:0051610 | serotonin uptake(GO:0051610) |
0.1 | 1.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.5 | GO:0021586 | pons maturation(GO:0021586) |
0.1 | 1.1 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.1 | 0.8 | GO:0070384 | Harderian gland development(GO:0070384) |
0.1 | 2.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.8 | GO:0034651 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.1 | 0.8 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.3 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 0.4 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.1 | 1.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.4 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.1 | 0.6 | GO:1903365 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
0.1 | 0.4 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.6 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.1 | 0.9 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.1 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.1 | 0.6 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.8 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.4 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.2 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.4 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.1 | 0.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.5 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.1 | 0.7 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.6 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.5 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.1 | 0.2 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 1.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.4 | GO:1901738 | regulation of vitamin A metabolic process(GO:1901738) |
0.1 | 0.5 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.3 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.1 | 1.9 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.7 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.5 | GO:1905077 | negative regulation of interleukin-17 secretion(GO:1905077) |
0.1 | 0.3 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.3 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 1.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 0.4 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.1 | 0.3 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.1 | 0.7 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.1 | 0.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.4 | GO:0032382 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) positive regulation of sterol import(GO:2000911) |
0.1 | 0.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.1 | GO:0090194 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
0.1 | 1.4 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 2.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.1 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.1 | 1.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 1.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.4 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.1 | 0.5 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.1 | 0.9 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.4 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.4 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.1 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.1 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.1 | 0.4 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.1 | 0.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.3 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.1 | 0.3 | GO:0003274 | endocardial cushion fusion(GO:0003274) |
0.1 | 0.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.6 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.2 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.1 | 1.6 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.1 | 0.6 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 1.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.2 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.3 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.1 | 0.3 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.3 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.1 | 0.9 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 1.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.6 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.3 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.1 | 0.5 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.1 | 1.3 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.3 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.1 | 0.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 1.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.4 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.1 | 0.1 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) |
0.1 | 1.7 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 1.2 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 0.5 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 0.4 | GO:0009744 | fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 0.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 2.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 2.4 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.4 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
0.1 | 2.6 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.2 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.3 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.1 | 0.6 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.7 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.1 | 0.2 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.1 | 0.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.4 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.7 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.5 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.3 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.1 | 0.1 | GO:0072166 | posterior mesonephric tubule development(GO:0072166) |
0.1 | 0.4 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.1 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
0.1 | 0.3 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.1 | 0.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 1.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.3 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
0.1 | 0.7 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 1.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.7 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.1 | 0.9 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 1.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.3 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
0.1 | 0.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 0.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.9 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.3 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.1 | 1.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.6 | GO:0090003 | regulation of Golgi to plasma membrane protein transport(GO:0042996) regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.1 | 0.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.3 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.1 | 0.2 | GO:0071374 | response to parathyroid hormone(GO:0071107) cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 1.7 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.9 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 1.0 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.4 | GO:0046882 | negative regulation of gonadotropin secretion(GO:0032277) negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.2 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.1 | 1.4 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.1 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 1.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.1 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.1 | 0.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.3 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.9 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 0.5 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 0.6 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.5 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.8 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.1 | 0.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 1.1 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.4 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.4 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 0.2 | GO:2000864 | estradiol secretion(GO:0035938) regulation of estradiol secretion(GO:2000864) |
0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 | 1.5 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 0.6 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 0.2 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.1 | 0.2 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.1 | 0.5 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 1.1 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.1 | 0.2 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.1 | 0.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 1.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 1.5 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 0.4 | GO:1990839 | response to endothelin(GO:1990839) |
0.1 | 0.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.1 | 0.3 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.7 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.6 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 1.1 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.7 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.3 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.1 | 0.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.1 | 0.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 1.0 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.2 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.3 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.3 | GO:0060596 | mammary placode formation(GO:0060596) |
0.1 | 0.4 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.1 | 0.6 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.1 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
0.1 | 0.3 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.1 | 0.2 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.1 | 0.2 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.1 | 0.6 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 2.3 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.5 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.5 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 0.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 3.1 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.4 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 1.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.3 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.1 | 0.2 | GO:0061312 | BMP signaling pathway involved in heart development(GO:0061312) |
0.1 | 0.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.1 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.7 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 0.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.1 | 0.2 | GO:0003342 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) epicardium morphogenesis(GO:1905223) |
0.1 | 1.2 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.3 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.1 | 0.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.1 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.1 | 1.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 2.9 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.1 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.1 | 2.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.1 | GO:0061010 | gall bladder development(GO:0061010) |
0.1 | 0.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 3.5 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 1.0 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.1 | 0.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.7 | GO:0019068 | virion assembly(GO:0019068) |
0.1 | 0.5 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.3 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 0.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.7 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.6 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.2 | GO:0014889 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) muscle atrophy(GO:0014889) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.3 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.1 | GO:0021502 | neural fold elevation formation(GO:0021502) epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.7 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.2 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 0.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 1.7 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 1.3 | GO:0010043 | response to zinc ion(GO:0010043) |
0.1 | 0.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 1.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.4 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.2 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 1.0 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.1 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.1 | 0.4 | GO:1903299 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
0.1 | 0.2 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.1 | 0.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.6 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.5 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 1.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.2 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.2 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.1 | 1.5 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.4 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 1.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.2 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.1 | 0.5 | GO:0070431 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.2 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 0.4 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.3 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.1 | 0.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 1.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.4 | GO:0098597 | observational learning(GO:0098597) |
0.1 | 0.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 1.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.3 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.7 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.0 | 0.6 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.0 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.2 | GO:0015812 | gamma-aminobutyric acid secretion(GO:0014051) gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.2 | GO:0072014 | proximal tubule development(GO:0072014) |
0.0 | 0.1 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.0 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 0.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.0 | 0.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.0 | 0.8 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 0.3 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.0 | 0.1 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.0 | 0.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.0 | 0.4 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.6 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.2 | GO:0034760 | regulation of iron ion transport(GO:0034756) negative regulation of iron ion transport(GO:0034757) regulation of iron ion transmembrane transport(GO:0034759) negative regulation of iron ion transmembrane transport(GO:0034760) |
0.0 | 0.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 2.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.4 | GO:0002931 | response to ischemia(GO:0002931) |
0.0 | 0.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.0 | 0.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.6 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 0.2 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.0 | 1.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.1 | GO:0002276 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
0.0 | 2.3 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 0.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.0 | 0.0 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.0 | 0.2 | GO:0034380 | very-low-density lipoprotein particle remodeling(GO:0034372) high-density lipoprotein particle assembly(GO:0034380) |
0.0 | 1.4 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
0.0 | 0.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.4 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.3 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.4 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 0.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.6 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.0 | 0.4 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.0 | 0.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.0 | 0.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.7 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 | 2.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.2 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.0 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 1.4 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.6 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.0 | 0.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 1.4 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.2 | GO:1901380 | negative regulation of potassium ion transmembrane transport(GO:1901380) |
0.0 | 0.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.1 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.4 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 0.1 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.0 | 0.4 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.3 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 0.6 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.0 | 0.4 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.1 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.1 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 3.2 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.1 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
0.0 | 0.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.0 | 0.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.3 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.0 | 0.6 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.5 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.0 | 0.4 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.3 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.0 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.1 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.0 | 1.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.0 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) |
0.0 | 0.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.0 | 0.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.0 | 0.1 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.0 | 0.1 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.2 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.3 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.4 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.0 | GO:0032959 | positive regulation of norepinephrine secretion(GO:0010701) inositol trisphosphate biosynthetic process(GO:0032959) regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.0 | 0.3 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 1.0 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.2 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.1 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.0 | 0.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.0 | 0.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.5 | GO:0006497 | protein lipidation(GO:0006497) |
0.0 | 0.6 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.1 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.0 | 0.1 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.0 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.0 | 0.7 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.0 | 0.3 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.0 | 0.6 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.2 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.0 | 0.2 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.0 | 0.2 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 1.1 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.0 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.4 | GO:0021988 | olfactory lobe development(GO:0021988) |
0.0 | 0.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.3 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.0 | 0.1 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.0 | 0.0 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.2 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.0 | 0.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.0 | 0.2 | GO:2001199 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.7 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.0 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.0 | 0.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.0 | 0.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:1901725 | negative regulation of histone deacetylation(GO:0031064) regulation of histone deacetylase activity(GO:1901725) |
0.0 | 0.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.2 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.0 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.6 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.0 | 0.3 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.0 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.0 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 0.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.0 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.0 | 0.2 | GO:0034312 | diol biosynthetic process(GO:0034312) |
0.0 | 0.3 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.0 | 0.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.0 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.0 | 0.1 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.1 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.3 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) regulation of nonmotile primary cilium assembly(GO:1902855) |
0.0 | 0.0 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.0 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.1 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.0 | 0.1 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.0 | 0.2 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.0 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.4 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.8 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.0 | 0.0 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.0 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.0 | 0.1 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.3 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.1 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.0 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.0 | 0.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.1 | GO:0045056 | transcytosis(GO:0045056) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.7 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.0 | 0.0 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.0 | 0.2 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.0 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.0 | 0.0 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.0 | GO:1904377 | positive regulation of protein localization to cell periphery(GO:1904377) |
0.0 | 0.2 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.0 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.0 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) |
0.0 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.1 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.5 | 4.8 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.5 | 2.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.5 | 2.4 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.4 | 1.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.4 | 1.7 | GO:0097574 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
0.4 | 4.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 1.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.4 | 6.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 1.0 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.3 | 1.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 0.8 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.3 | 0.3 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
0.3 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 1.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.2 | 4.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 1.0 | GO:0090537 | CERF complex(GO:0090537) |
0.2 | 2.4 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 0.7 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.2 | 0.7 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.2 | 1.2 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.2 | 1.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 1.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 2.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 1.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.6 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.2 | 1.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 1.0 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 2.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 1.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 0.7 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.2 | 1.2 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 0.5 | GO:0098855 | HCN channel complex(GO:0098855) |
0.2 | 1.7 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 1.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 3.9 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 1.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 1.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 1.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 1.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.9 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 0.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 1.2 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.1 | 0.7 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.1 | 1.1 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.1 | 1.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.4 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 3.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.6 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 3.9 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.7 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 1.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 2.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 2.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.6 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.3 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 1.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 1.4 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 1.8 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 0.6 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.4 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.8 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.3 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.5 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 0.7 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.1 | 0.4 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 0.5 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 3.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.5 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 0.4 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.1 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 1.5 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 4.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 1.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 0.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.1 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
0.1 | 0.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 3.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.5 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.3 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 1.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.3 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
0.1 | 0.3 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.6 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.2 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.6 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 3.0 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.4 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 0.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.7 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.5 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.4 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 2.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.4 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.6 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.0 | 2.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.8 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 1.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 5.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 1.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 2.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 0.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 1.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 1.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 3.9 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.0 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.0 | 0.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.4 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 0.3 | GO:0044754 | autolysosome(GO:0044754) |
0.0 | 0.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.7 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.0 | 0.9 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 4.5 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.1 | GO:0097444 | spine apparatus(GO:0097444) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 1.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.5 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.1 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.0 | 0.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.8 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.5 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 15.6 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.5 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.2 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 1.8 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.4 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.1 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.0 | 1.6 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.2 | GO:0035939 | microsatellite binding(GO:0035939) |
0.9 | 2.7 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
0.8 | 4.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.5 | 2.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.5 | 2.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.5 | 1.5 | GO:0019002 | GMP binding(GO:0019002) |
0.5 | 1.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.5 | 1.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.5 | 1.8 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.4 | 1.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.4 | 3.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.4 | 2.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.4 | 2.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 1.2 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.4 | 2.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.4 | 1.6 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.4 | 1.1 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.4 | 1.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.4 | 1.1 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.4 | 2.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 2.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 3.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 0.9 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.3 | 1.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 1.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.3 | 1.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.3 | 0.9 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.3 | 2.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.3 | 0.8 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.3 | 1.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 0.8 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.3 | 1.8 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.3 | 0.8 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.3 | 2.0 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 2.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 2.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 5.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 0.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 1.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.7 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
0.2 | 0.7 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.2 | 1.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 1.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 0.7 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
0.2 | 0.7 | GO:0071077 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.2 | 0.9 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.2 | 0.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 1.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 0.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 0.6 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.2 | 1.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 1.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 2.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.7 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 0.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.2 | 0.7 | GO:0050436 | microfibril binding(GO:0050436) |
0.2 | 1.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 0.5 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.2 | 0.5 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
0.2 | 0.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.2 | 1.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 1.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 0.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.2 | 0.5 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 1.5 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.2 | 1.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 1.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 0.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 1.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 1.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 0.5 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.2 | 1.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 1.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 1.8 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 1.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.6 | GO:0070976 | TIR domain binding(GO:0070976) |
0.1 | 0.6 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.1 | 0.4 | GO:0034188 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.1 | 2.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 1.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 1.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.4 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 1.0 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
0.1 | 0.4 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.1 | 3.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 1.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.5 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.1 | 1.0 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 0.6 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.4 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.1 | 0.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 2.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 2.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.4 | GO:0036004 | GAF domain binding(GO:0036004) |
0.1 | 0.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 1.9 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.4 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.1 | 1.5 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 1.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 1.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.4 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.4 | GO:0050632 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
0.1 | 0.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.7 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 1.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 2.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 1.1 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 1.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.4 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 0.5 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 1.7 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.5 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 0.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 2.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 1.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 2.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.5 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 0.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 1.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.3 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.1 | 0.9 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.3 | GO:0047936 | glucose 1-dehydrogenase [NAD(P)] activity(GO:0047936) |
0.1 | 0.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 0.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 1.3 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.3 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.1 | 1.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.4 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 2.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 1.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.3 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
0.1 | 1.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 1.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 2.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 1.6 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.1 | 0.7 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 1.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 4.6 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 2.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 1.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.2 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.4 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 1.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.3 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.8 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.1 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 0.4 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.1 | 0.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 2.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.2 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.1 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.6 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.3 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 0.5 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 0.7 | GO:0070492 | peptidoglycan binding(GO:0042834) oligosaccharide binding(GO:0070492) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.5 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.1 | 0.2 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.1 | 0.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.4 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.2 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.1 | 0.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.1 | 0.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 2.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.2 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.1 | 0.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.2 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 2.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 0.3 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 0.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 2.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.2 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.1 | 0.2 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.2 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.1 | 0.2 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 1.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 1.0 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.2 | GO:0031208 | POZ domain binding(GO:0031208) |
0.1 | 0.9 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.6 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 1.5 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.2 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.5 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0030984 | kininogen binding(GO:0030984) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:1902121 | lithocholic acid binding(GO:1902121) |
0.0 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.2 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.4 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 1.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.0 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 1.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.5 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 1.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 1.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 2.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 4.9 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 2.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.0 | 0.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 1.0 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.7 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 1.3 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 1.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 4.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 5.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 2.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.7 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.3 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.7 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.9 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 1.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 0.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 0.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.4 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.0 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.4 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.0 | 0.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 1.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.0 | 0.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.2 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.2 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 0.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.0 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.5 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 2.2 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.2 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.0 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.0 | 0.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 1.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 1.0 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.0 | GO:0055100 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
0.0 | 1.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.0 | 1.8 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.6 | GO:0046906 | heme binding(GO:0020037) tetrapyrrole binding(GO:0046906) |
0.0 | 0.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.0 | 0.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.1 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.4 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 0.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.4 | GO:0005179 | hormone activity(GO:0005179) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 2.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 1.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 4.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 2.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 2.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 4.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 1.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 3.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 2.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 5.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 3.8 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 4.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 1.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 2.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 3.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 3.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 1.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 4.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 4.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 3.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.4 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 3.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 1.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 4.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 1.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 5.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 1.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 2.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.4 | PID NOTCH PATHWAY | Notch signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.7 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.2 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 1.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 3.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 2.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 4.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 5.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.4 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 1.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.2 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 1.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 2.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 5.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 3.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 3.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 2.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 2.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 3.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.0 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 1.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 2.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 2.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 1.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 1.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 1.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 1.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.2 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.0 | 0.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.7 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 1.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 1.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 3.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 1.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.9 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 1.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 3.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.9 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 2.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.2 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.0 | 0.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.4 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.0 | 0.5 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.6 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.1 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |